← back to search

Xuelian Ning

Harbin Medical University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research focused on Cancer research and Alternative splicing, with related work in DNA repair, RNA splicing, Colorectal cancer. Notable publications include 'ARID3A promotes the development of colorectal cancer by upregulating AURKA', 'An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling', and 'Proteomic Profiling of Paclitaxel Treated Cells Identifies a Novel Mechanism of Drug Resistance Mediated by PDCD4'.
h-index
citations
141
works
9
NIH funding
primary concept
email

Recent publications

The role of alternative splicing in lung cancer
Cancer Chemotherapy and Pharmacology 2023cited by 2position: firstdoi
Alternative splicing: An important regulatory mechanism in colorectal carcinoma
Molecular Carcinogenesis 2021cited by 10position: middledoi
ARID3A promotes the development of colorectal cancer by upregulating AURKA
Carcinogenesis 2020cited by 46position: middledoi
Loss of tumor suppressor inositol polyphosphate 4-phosphatase type B impairs DNA double-strand break repair by destabilization of DNA tethering protein Rad50
Cell Death and Disease 2020cited by 13position: middledoi
A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome
BMC Cancer 2019cited by 7position: middledoi
Application and development of 3D printing technology in Biology
Int J Genet 2016cited by 0position: middledoi
Role of non-coding RNA in DNA damage response and repair
Int J Genet 2016cited by 0position: firstdoi
An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling
PLoS ONE 2015cited by 35position: middledoi
Proteomic Profiling of Paclitaxel Treated Cells Identifies a Novel Mechanism of Drug Resistance Mediated by PDCD4
Journal of Proteome Research 2015cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hui Xu · Guangzhou University of Chinese Medicine4 papers (2015–2020)Chunshui Zhou · Minzu University of China4 papers (2015–2020)Songbin Fu · Ministry of Education of the People's Republic of China4 papers (2015–2020)Jiandong Hu · Harbin Medical University3 papers (2016–2020)Yue Sun · Guiyang Medical University3 papers (2015–2020)Xiaohong Qiu · Harbin Medical University3 papers (2016–2020)Baogang Liu · Sun Yat-sen University Cancer Center3 papers (2015–2019)Jiawei Liu · BGI Group (China)2 papers (2015–2015)Shaochun Dai · Harbin Medical University2 papers (2015–2015)Shuoshuo Wang · Harbin Medical University2 papers (2021–2023)Jing Tang · Harbin Medical University2 papers (2020–2021)Huiying Sun · Harbin Medical University2 papers (2015–2015)Yanting Jiang · Harbin Medical University2 papers (2019–2020)Fangfang Fan · King University2 papers (2015–2015)Lirui Yang · Harbin Medical University2 papers (2020–2021)Haiyuan Zhang · Harbin Institute of Technology2 papers (2015–2015)Tianzhen Wang · Jiangsu University2 papers (2020–2021)Yilan Li · Ministry of Education of the People's Republic of China2 papers (2015–2019)Anita Chaulagain · Harbin Medical University2 papers (2020–2021)Steven P. Gygi · Harvard University2 papers (2015–2020)